Oramed Pharmaceuticals
ORMP
#9078
Rank
HK$1.32 B
Marketcap
HK$32.47
Share price
-0.48%
Change (1 day)
79.82%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): HK$0.61 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of HK$0.61 Billion, an increase over its 2024 earnings that were of -HK$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$0.61 B0.42%
2025 HK$0.61 B-616.9%
2024 -HK$0.12 Billion-311.47%
2023 HK$55.87 M-119.45%
2022 -HK$0.29 Billion39.17%
2021 -HK$0.21 Billion73.93%
2020 -HK$0.12 Billion18.53%
2019 -HK$0.11 Billion-16.62%
2018 -HK$0.13 Billion38.32%
2017 -HK$86.81 Million12.51%
2016 -HK$77.15 Million25.01%
2015 -HK$61.72 Million18.18%
2014 -HK$52.23 Million39.72%
2013 -HK$37.38 Million46.4%
2012 -HK$25.54 Million128.32%
2011 -HK$11.19 Million-51.47%
2010 -HK$23.05 Million35.21%
2009 -HK$17.05 Million
2007 -HK$26.8 Million607.04%
2006 -HK$3.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
HK$196.14 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
HK$60.05 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-HK$4.21 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-HK$0.21 Billion-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
HK$0.27 B-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel